Laurion Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-19,536	Closed	-$1.53M	–	718
2019 Q1	$1.53M	Buy	+19,536	New	+$1.53M	0.02%	230
2018 Q2	–	Sell	-3,206	Closed	-$330K	–	1183
2018 Q1	$330K	Buy	+3,206	New	+$330K	﹤0.01%	834